{"schema_version":"secwatch.filing_event.v1","accession":"0001618835-22-000142","form_type":"8-K","ticker":"EVFM","cik":"0001618835","company_name":"Evofem Biosciences, Inc.","filed_at":"2022-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.381100+00:00","generated_at":"2026-06-24T05:12:48.917104+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Evofem Biosciences appoints Jenny Yip from Adjuvant Capital to board of directors","bullets":["Jenny Yip, Managing Partner at Adjuvant Capital, elected to Evofem board effective August 2, 2022.","Adjuvant Capital previously invested $25 million to fund Phase 3 EVOGUARD trial for Phexxi in chlamydia/gonorrhea prevention.","Top-line results from EVOGUARD trial expected fall 2022.","Board expands from five to six independent directors with Yip's appointment.","Yip's term expires at 2023 annual meeting; standard indemnification agreement entered."],"urls":{"canonical":"https://secwatch.observer/filing/0001618835-22-000142","json":"https://secwatch.observer/filing/0001618835-22-000142.json","markdown":"https://secwatch.observer/filing/0001618835-22-000142.md","text":"https://secwatch.observer/filing/0001618835-22-000142.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1618835/000161883522000142/0001618835-22-000142-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1618835/000161883522000142/evfm-20220802.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T05:12:48.917104+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0937503174","claim":"Jenny Yip was elected as Director at Evofem Biosciences, Inc..","evidence_excerpt":"On August 2, 2022, the Board of Directors (the “Board”) of Evofem Biosciences, Inc., a Delaware corporation (the “Company”), elected Jenny Yip, to the Board to fill the existing vacancy on the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1618835/000161883522000142/0001618835-22-000142-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}